We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An Indian affiliate of GlaxoSmithKline (GSK), 49.2 percent owned by the UK-based
drug major, has announced it will offer joint marketing deals to Western entrants,
as the multinational sector interest in India continues to build.
Pharmaceutical producers in Bangladesh stand to gain
considerably from the implementation of neighbouring India's new World Trade
Organisation (WTO)-compliant patent law.
According to Mexican OTC medicines producers' association AFAMELA,
OTC medicines accounted for 33 percent of local drug unit sales in the first
eleven months of 2004, and roughly 18 percent of the market in terms of sales.
Farmaindustria, a group representing drugmakers in Spain, has denied
that a massive effort to change price labelling on more than 3,000 products
has led to shortages of vital medicines.
Wockhardt, a medium-sized Indian drugmaker, has announced plans to
acquire a German firm this year, as the company attempts to expand its European
presence.
Leading Japanese drug producer Takeda has reported positive results
for the first three quarters of the fiscal year ending March 2005, as its leading
products continue to win global market share.
Japanese drugmaker Shionogi has reported a 2.9 percent fall in its
turnover in the first three quarters of the fiscal year ending March 2005 to
JPY151.8bn (US$1.45bn).